Mammary Neoplasms, Animal
"Mammary Neoplasms, Animal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).
Concept/Terms
Mammary Neoplasms, Animal- Mammary Neoplasms, Animal
- Animal Mammary Neoplasm
- Animal Mammary Neoplasms
- Mammary Neoplasm, Animal
- Neoplasm, Animal Mammary
- Neoplasms, Animal Mammary
- Neoplasms, Mammary
- Mammary Neoplasms
- Mammary Neoplasm
- Neoplasm, Mammary
Mammary Carcinoma, Animal- Mammary Carcinoma, Animal
- Animal Mammary Carcinomas
- Carcinoma, Animal Mammary
- Carcinomas, Animal Mammary
- Mammary Carcinomas, Animal
- Animal Mammary Carcinoma
Below are MeSH descriptors whose meaning is more general than "Mammary Neoplasms, Animal".
Below are MeSH descriptors whose meaning is more specific than "Mammary Neoplasms, Animal".
This graph shows the total number of publications written about "Mammary Neoplasms, Animal" by people in Harvard Catalyst Profiles by year, and whether "Mammary Neoplasms, Animal" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 1 | 2 |
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 3 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 2 | 2 | 4 |
| 2006 | 6 | 0 | 6 |
| 2007 | 2 | 3 | 5 |
| 2009 | 6 | 2 | 8 |
| 2010 | 4 | 3 | 7 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 2 | 5 |
| 2013 | 2 | 3 | 5 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 5 | 1 | 6 |
| 2017 | 3 | 2 | 5 |
| 2018 | 4 | 1 | 5 |
| 2019 | 3 | 1 | 4 |
| 2020 | 3 | 0 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 3 | 0 | 3 |
| 2023 | 5 | 0 | 5 |
Below are the most recent publications written about "Mammary Neoplasms, Animal" by people in Profiles.
-
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer. Nat Commun. 2023 09 13; 14(1):5665.
-
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer J Pathol. 2023 08; 260(5):498-513.
-
Evaluating the effects of radiation and acoustically-stimulated microbubble therapy in an in vivo breast cancer model. PLoS One. 2023; 18(5):e0277759.
-
PI3Kß controls immune evasion in PTEN-deficient breast tumours. Nature. 2023 May; 617(7959):139-146.
-
Establishment and Culture of Patient-Derived Breast Organoids. J Vis Exp. 2023 02 17; (192).
-
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat Cancer. 2023 01; 4(1):128-147.
-
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression. J Clin Invest. 2022 12 01; 132(23).
-
Characterization and function of extracellular vesicles in a canine mammary tumour cell line: Ultracentrifugation versus size exclusion chromatography. Vet Comp Oncol. 2023 Mar; 21(1):36-44.
-
Adipocyte mesenchymal transition contributes to mammary tumor progression. Cell Rep. 2022 09 13; 40(11):111362.
-
Protective immune response against P32 oncogenic peptide-pulsed PBMCs in mouse models of breast cancer. Int Immunopharmacol. 2021 Apr; 93:107414.